Outlook Therapeutics Inc (OTLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2015 | 12-2014 | 09-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -48,670 | 0 | -13,733 | 0 | N/A |
| Depreciation Amortization | 1,825 | 0 | 879 | 0 | N/A |
| Accounts receivable | -20 | 0 | N/A | 0 | N/A |
| Accounts payable and accrued liabilities | 6,581 | 0 | -96 | 0 | N/A |
| Other Working Capital | 8,179 | 0 | 1,863 | 0 | N/A |
| Other Operating Activity | 4,630 | 0 | 4,067 | 0 | 0 |
| Operating Cash Flow | $-27,476 | $0 | $-7,021 | $0 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8,804 | 0 | -2,367 | 0 | N/A |
| Investing Cash Flow | $-8,804 | $0 | $-2,367 | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,880 | 0 | 8,460 | 0 | N/A |
| Debt Repayment | -9,301 | 0 | -4,073 | 0 | N/A |
| Common Stock Issued | 41,250 | 0 | 11,043 | 0 | N/A |
| Other Financing Activity | 173 | 0 | -3,957 | 0 | 0 |
| Financing Cash Flow | $43,002 | $0 | $11,474 | $0 | $N/A |
| Beginning Cash Position | 2,349 | 0 | 262 | 0 | N/A |
| End Cash Position | 9,071 | 0 | 2,349 | 0 | N/A |
| Net Cash Flow | $6,722 | $0 | $2,087 | $0 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,476 | 0 | -7,021 | 0 | N/A |
| Capital Expenditure | -8,804 | 0 | -2,367 | 0 | N/A |
| Free Cash Flow | -36,280 | 0 | -9,387 | 0 | 0 |